The resistance against Listeria monocytogenes and the formation of germinal centers depend on a functional death domain of the 55 kDa tumor necrosis factor receptor

European Journal of Immunology

Volumn 29, Issue 2, 1999, Pages 581-591

  Plitz, Thomas ^a   Huffstadt, Ulrike ^a   Endres, Robert ^a   Schaller, Evelyn ^a   Mak, Tak W ^b   Wagner, Hermann ^a   Pfeffer, Klaus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Death domain; Germinal center; Listeriosis; TNF receptor; Transgene

Indexed keywords

ADDRESSIN; CELL ADHESION MOLECULE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GERMINAL CENTER; INFECTION RESISTANCE; LISTERIA MONOCYTOGENES; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; SPLEEN; TRANSGENE;

ANIMALS; ANTIGENS, CD; GERMINAL CENTER; IMMUNITY, NATURAL; LISTERIA INFECTIONS; MICE; MICE, TRANSGENIC; MUTATION; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032990256     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199902)29:02<581::AID-IMMU581>3.0.CO;2-A     Document Type: Article

References (59)

1. Beutler, B. and Van Huffel, C., Unraveling function in the TNF ligand and receptor families. Science 1994. 264: 667-668.
2. Beutler B, and Cerami, A., Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu. Rev. Biochem. 1988. 57: 505-518.
3. Blanchard, D. K., TNF in Legionella infection. In Beutler, B. (Ed.) Tumor necrosis factors: the molecules and their emerging role in medicine. Raven Press, New York 1992, pp 293-302.
4. Nakane, A., TNF in Listeriosis. In Beutler, B. (Ed.) Tumor necrosis factors: the molecules and their emerging role in medicine. Raven Press, New York 1992, pp 285-292.
5. Grau, G. E., Parida, S. K., Pointaire, P., Barnes, P. F. and Modlin, R., TNF and Mycobacteria. In Beutler, B. (Ed.) Tumor necrosis factors: the molecules and their emerging role in medicine. Raven Press, New York 1992, pp 329-340.
6. Clark, I. A., Rockett, K. A. and Cowden, W. B., TNF in Malaria. In Beutler, B. (Ed.) Tumor necrosis factors: the molecules and their emerging role in medicine. Raven Press, New York 1992, pp 303-328.
7. Pfeffer, K., Matsuyama, T., Kundig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Kranke, M. and Mak, T. W., Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993. 73: 457-467.
8. Rothe, J., Lesslauer, W., Lotscher, H., Lang, Y., Koebel, P., Kontgen, F., Althage A., Zinkernagel, R., Steinmetz, M. and Bluethmann, H., Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993. 364: 798-802.
9. Endres, R., Luz, A., Schulze, H., Neubauer, H., Futterer, A., Holland, S. M., Wagner, H. and Pfeffer, K., Listeriosis in p47(phox-/-) and Rp55-/-mice: protection despite absence of ROI and susceptibility despite presence of RNI. Immunity 1997. 7: 419-432.
10. Erickson, S. L., de Sauvage, F. J., Kikly, K., Carver-Moore, K., Pitts-Meek, S., Gillett, N., Sheehan, K. C., Schreiber, R. D., Goeddel, D. V. and Moore, M. W., Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor 2-deficient mice. Nature 1994. 372: 560-563.
11. Neumann, B., Luz, A., Pfeffer, K. and Holzmann, B., Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor. J. Exp. Med. 1996. 184: 259-264.
12. Pasparakis, M., Alexopoulou, L, Grell, M., Pfizenmaier, K., Bluethmann, H. and Kollias, G., Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor [published erratum appears in Proc. Acad. Sci. USA 1997. 94:9510]. Proc. Natl, Acad. Sci. USA 1997. 94: 6319-6323.
13. Futterer, A., Mink, K., Luz, A., Kosco-Vilbois, M. H. and Pfeffer, K., The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998. 9: 59-70.
14. De Togni, P., Goellner, J., Ruddle, N. H., Streeter, P. R., Fick, A., Mariathasan, S., Smith, S. C., Carlson, R., Shornick, L. P. and Strauss-Schoenberger, J., Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994. 264: 703-707.
15. Alimzhanov, M. B., Kuprash, D. V., Kosco-Vilbois, M. H., Luz, A., Turetskaya, R. L, Tarakhovsky, A., Rajewsky, K., Nedospasov, S. A. and Pfeffer, K., Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc.Natl.Acad.Sci. USA 1997. 94: 9302-9307.
16. Koni, P. A., Sacca, R., Lawton, P., Browning, J. L., Ruddle, N. H. and Flavell, R. A., Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity 1997. 6: 491-500.
17. Matsumoto, M., Mariathasan, S., Nahm, M. H., Baranyay, F, Peschon, J. J. and Chaplin, D. D., Role of lymphotoxin and the type 1 TNF receptor in the formation of germinal centers. Science 1996. 271: 1289-1291.
18. Mackay, F., Majeau, G. R., Lawton, P., Hochman, P. S. and Browning, J.L., Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur.J.Immunol. 1997. 27: 2033-2042.
19. Pasparakis, M., Alexopoulou, L., Episkopou, V. and Kollias, G., Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J.Exp.Med. 1996. 184: 1397-1411.
20. Tkachuk, M., Bolliger, S., Ryffel, B., Pluschke, G., Banks, T. A., Herren, S., Gisler, R. H. and Kosco-Vilbois, M. H., Crucial role of tumor necrosis factor receptor 1 expression on nonhematopoietic cells for B cell localization within the splenic white pulp. J.Exp.Med. 1998. 187: 469-477.
21. Neumann, B., Machleidt, T., Lifka, A., Pfeffer, K., Vestweber, D., Mak, T. W., Holzmann, B. and Kronke, M., Cruciale role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J.Immunol. 1996. 156: 1587-1593.
22. Matsumoto, M., Fu, Y. X., Molina, H. and Chaplin, D. D., Lymphotoxin-alpha-deficient and TNF receptor-I-deficient mice define developmental and functional characteristics of germinal centers, Immunol.Rev. 1997. 156: 137-144.
23. Matsumoto, M., Fu, Y. X., Molina, H., Huang, G., Kim, J., Thomas, D. A., Nahm, M. H. and Chaplin, D. D., Distinct roles of lymphotoxin alpha and the type I tumor necrosis factor (TNF) receptor in the establishment of follicular dendritic cells from non-bone marrow-derived cells. J.Exp.Med. 1997. 186: 1997-2004.
24. Fu, Y. X., Huang, G., Wang, Y. and Chaplin, D. D., B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion. J.Exp.Med. 1998. 187: 1009-1018.
25. Gonzalez, M., Mackay, F., Browning, J. L., Kosco-Vilbois, M. H. and Noelle, R. J., The sequential role of lymphotoxin and B cells in the development of splenic follicles. J.Exp.Med. 1998. 187: 997-1007.
26. Liu, Z. G., Hsu, H., Goeddel, D. V. and Karin, M., Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 1996. 87: 565-576.
27. Nishina, H., Fischer, K. D., Radvanyi, L., Shahinian, A., Hakem, R., Rubie, E. A., Bernstein, A., Mak, T. W., Woodgett, J. R. and Penninger, J. M., Stress-signalling kinase Sek 1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 1997. 385: 350-353.
28. Chinnaiyan, A. M., Tepper, C. G., Seldin, M. F., O'Rourke, K., Kischkel, F. C., Hellbardt, S., Krammer, P.H., Peter, M. E. and Dixit, V.M., FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J.Biol.Chem. 1996. 271: 4961-4965.
29. Varfolomeev, E. E., Schuchmann, M., Luria, V., Chiannilkulchai, N., Beckmann, J. S., Mett, I. L., Rebrikov, D., Brodianski, V. M., Kemper, O. C., Kollet, O., Lapidot, T., Soffer, D., Sobe, T., Avraham, K. B., Goncharov, T., Holtmann, H., Lonai, P. and Wallach, D., Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 1998. 9: 267-276.
30. Yeh, W. C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J. L, Ferrick, D., Hum, B., Iscove, N., Ohashi, P., Rothe, M., Goeddel, D. V. and Mak, T. W., Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 1997. 7: 715-725.
31. Kelliher, M. A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B. Z. and Leder, P., The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 1998. 8: 297-303.
32. Malinin, N. L., Boldin, M. P., Kovalenko, A. V. and Wallach, D., MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 1997. 385: 540-544.
33. Regnier, C. H., Song, H. Y., Gao, X., Goeddel, D. V, Cao, Z. and Rothe, M., Identification and characterization of an IkappaB kinase. Cell 1997. 90: 373-383.
34. Woronicz, J. D., Gao, X., Cao, Z., Rothe, M. and Goeddel, D. V., IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 1997. 278: 866-869.
35. Natoli, G., Costanzo, A., Ianni, A., Templeton, D. J., Woodgett, J. R., Balsano, C. and Levrero, M., Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 1997. 275: 200-203.
36. Tartaglia, L. A., Ayres, T. M., Wong, G. H. and Goeddel, D. V., A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993. 74: 845-853.
37. Hsu, H., Xiong, J. and Goeddel, D. V, The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995. 81: 495-504.
38. Adam, D., Adam-Klages, S. and Kranke, M., Identification of p55 tumor necrosis factor receptor-associated proteins that couple to signaling pathways not initiated by the death domain. J. Inflamm. 1995. 47: 61-66.
39. Song, H. Y., Dunbar, J. D., Zhang, Y. X., Guo, D. and Donner, D. B., Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor. J.Biol.Chem. 1995. 270: 3574-3581.
40. Boldin, M. P., Mett, I. L. and Wallach, D., A protein related to proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its 'death domain'. FEBS Lett. 1995. 367: 39-44.
41. Lewis, M., Tartaglia, L. A., Lee, A., Bennett, G. L., Rice, G. C., Wong, G. H., Chen. E. Y. and Goeddel, D. V., Cloning and expression of cDNA for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc.Natl.Acad.Sci USA 1991. 88: 2830-2834.
42. Jat, P. S., Noble, M. D., Ataliotis, P., Tanaka, Y., Yannoutsos, N., Larsen, L. and Kioussis, D., Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc.Natl.Acad.Sci. USA 1991. 88: 5096-5100.
43. Galanos, C., Freudenberg, M. A. and Reutter, W., Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc.Natl.Acad.Sci. USA 1979. 76: 5939-5943.
44. Tiegs, G., Wolter, M. and Wendel, A., Tumor necrosis factor is a terminal mediator in galactosamine/ endotoxin-induced hepatitis in mice. Biochem.Pharmacol. 1989. 38: 627-631.
45. Beutler, B., Milsark, I. W. and Cerami, A. C., Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985. 229: 869-871.
46. Freudenberg, M. A. and Galanos, C., Tumor necrosis factor alpha mediates lethal activity of killed gramnegative and gram-positive bacteria in D-galactosaminetreated mice. Infect.Immun. 1991. 59: 2110-2115.
47. Tartaglia, L. A. and Goeddel, D. V., Tumor necrosis factor receptor signaling. A dominant negative mutation suppresses the activation of the 55-kDa tumor necrosis factor receptor. J.Biol.Chem. 1992. 267: 4304-4307.
48. Brakebusch, C., Nophar, Y, Kemper, O., Engelmann, H. and Wallach, D., Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor. EMBO J. 1992. 11: 943-950.
49. Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H. and Peter, M. E., Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBOJ. 1995. 14: 5579-5588.
50. Kinoshita, T., Fujita, TA. and Tsunoda, R., Expression of complement receptors CR1 and CR2 on murine follicular dendritic cells and B lymphocytes. In Imai, Y., Tew, J. G. and Hoefsmit, E. C. M. (Eds.) Dendritic cells in lymphoid tissues. Elsevier, Amsterdam 1991, pp 271-297.
51. Leist, M., Gantner, F., Bohlinger, I., Tiegs, G., Germann, P. G. and Wendel, A., Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am.J.Pathol. 1995. 146: 1220-1234.
52. Bekesi, J. G., Bekesi, E. and Winzler, R. J., Inhibitory effect of D-glucosamine and other sugars on the biosynthesis of protein, ribonucleic acid, and deoxyribonucleic acid in normal and neoplastic tissues. J.Biol.Chem. 1969. 244: 3766-3772.
53. Boldin, M. P., Mett, I. L., Varfolomeev, E. E., Chumakov, I., Shemer-Avni, Y., Camonis, J. H. and Wallach, D., Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J.Biol.Chem. 1995. 270: 387-391.
54. van Dullemen, H. M., van Deventer, S. J., Hommes, D. W., Bijl, H. A., Jansen, J., Tytgat, G. N. and Woody, J., Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995. 109: 129-135.
55. Feldmann, M., Brennan, F. M., Elliott, M. J., Williams, R. O. and Maini, R. N., TNF alpha is an effective therapeutic target for rheumatoid arthritis. Ann.N.Y.Acad.Sci. 1995. 766: 272-278.
56. Maini, R. N., Elliott, M. J., Brennan, F. M., Williams, R. O., Chu, C. Q., Paleolog, E., Charles, P. J., Taylor, P. C. and Feldmann, M., Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease. Immunol.Rev. 1995. 144: 195-223.
57. Kozak, M., Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res. 1984. 12: 857-872.
58. Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal.Biochem. 1987. 162: 156-169.
59. Wurst, W. and Joyner, A. L., Production of targeted embryonic stem cell clones. In Joyner, A. L. (Ed.) Gene targeting: a practical approach. IRL Press, Oxford 1993.